Wednesday, June 7, 2017

British Journal of Cancer - Table of Contents alert Volume 116 Issue 12

If you are unable to see the message below, click here to view.
British Journal of Cancer


Volume 116, Issue 12 (1499-1659)
Published online 6 June 2017

In this issue
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics

Also new today
Advance online publication
Digital Edition
Sign up for e-alerts Follow BJC on Twitter Follow us on Twitter

Sign up for e-alerts
Recommend to your library
Web feed



One-carbon metabolism in cancer

Alice C Newman and Oliver D K Maddocks

Br J Cancer 2017 116: 1499-1504; advance online publication, May 4, 2017; 10.1038/bjc.2017.118

Abstract | Full Text

Clinical Studies


Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignancies

Rastislav Bahleda, Juneko E Grilley-Olson, Ramaswamy Govindan, Fabrice Barlesi, Laurent Greillier, Maurice Perol, Isabelle Ray-Coquard, Dirk Strumberg, Beate Schultheis, Grace K Dy, Gérard Zalcman, Glen J Weiss, Annette O Walter, Martin Kornacker, Prabhu Rajagopalan, David Henderson, Hendrik Nogai, Matthias Ocker and Jean-Charles Soria

Br J Cancer 2017 116: 1505-1512; advance online publication, May 2, 2017; 10.1038/bjc.2017.92

Abstract | Full Text

A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases

Muhammed R S Siddiqui, Constantinos Simillis, Chris Hunter, Manish Chand, Jemma Bhoday, Aurelie Garant, Te Vuong, Giovanni Artho, Shahnawaz Rasheed, Paris Tekkis, Al-Mutaz Abulafi and Gina Brown

Br J Cancer 2017 116: 1513-1519; advance online publication, April 27, 2017; 10.1038/bjc.2017.99

Abstract | Full Text

Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study

Luca Triggiani, Filippo Alongi, Michela Buglione, Beatrice Detti, Riccardo Santoni, Alessio Bruni, Ernesto Maranzano, Frank Lohr, Rolando D’Angelillo, Alessandro Magli, Alberto Bonetta, Rosario Mazzola, Nadia Pasinetti, Giulio Francolini, Gianluca Ingrosso, Fabio Trippa, Sergio Fersino, Paolo Borghetti, Paolo Ghirardelli and Stefano Maria Magrini

Br J Cancer 2017 116: 1520-1525; advance online publication, April 27, 2017; 10.1038/bjc.2017.103

Abstract | Full Text

Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab

A Custodio, A Carmona-Bayonas, P Jiménez-Fonseca, M L Sánchez, A Viudez, R Hernández, J M Cano, I Echavarria, C Pericay, M Mangas, L Visa, E Buxo, T García, A Rodríguez Palomo, F Álvarez Manceñido, A Lacalle, I Macias, A Azkarate, A Ramchandani, A Fernández Montes, C López, F Longo, R Sánchez Bayona, M L Limón, A Díaz-Serrano, A Hurtado, R Madero, C Gómez and J Gallego on behalf of the AGAMENON study group

Br J Cancer 2017 116: 1526-1535; advance online publication, May 2, 2017; 10.1038/bjc.2017.122

Abstract | Full Text

Comorbid conditions delay diagnosis of colorectal cancer: a cohort study using electronic primary care records

Luke T A Mounce, Sarah Price, Jose M Valderas and William Hamilton

Br J Cancer 2017 116: 1536-1543; advance online publication, May 11, 2017; 10.1038/bjc.2017.127

Abstract | Full Text

Efficacy and safety of gemcitabine plus S-1 in pancreatic cancer: a pooled analysis of individual patient data

Chikuma Hamada, Takuji Okusaka, Takaaki Ikari, Hiroyuki Isayama, Junji Furuse, Hiroshi Ishii, Yousuke Nakai, Shogo Imai and Shota Okamura

Br J Cancer 2017 116: 1544-1550; advance online publication, May 4, 2017; 10.1038/bjc.2017.128

Abstract | Full Text

GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project

Sally C Benton, Piers Butler, Katy Allen, Michelle Chesters, Sally Rickard, Sally Stanley, Richard Roope, Daniel Vulkan and Stephen W Duffy

Br J Cancer 2017 116: 1551-1557; advance online publication, May 18, 2017; 10.1038/bjc.2017.129

Abstract | Full Text

Translational Therapeutics


Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases

Sagun Parakh, John J Park, Shehara Mendis, Rajat Rai, Wen Xu, Serigne Lo, Martin Drummond, Catherine Rowe, Annie Wong, Grant McArthur, Andrew Haydon, Miles C Andrews, Jonathan Cebon, Alex Guminski, Richard F Kefford, Georgina V Long, Alexander M Menzies, Oliver Klein and Matteo S Carlino

Br J Cancer 2017 116: 1558-1563; advance online publication, May 18, 2017; 10.1038/bjc.2017.142

Abstract | Full Text

Molecular Diagnostics


Mutation status among patients with sinonasal mucosal melanoma and its impact on survival

Moran Amit, Samantha Tam, Ahmed S Abdelmeguid, Dianna B Roberts, Yoko Takahashi, Shaan M Raza, Shirley Y Su, Michael E Kupferman, Franco DeMonte and Ehab Y Hanna

Br J Cancer 2017 116: 1564-1571; advance online publication, May 11, 2017; 10.1038/bjc.2017.125

Abstract | Full Text

Inhibition of neurotensin receptor 1 induces intrinsic apoptosis via let-7a-3p/Bcl-w axis in glioblastoma

Zhen Dong, Qian Lei, Rui Yang, Shunqin Zhu, Xiao-Xue Ke, Liqun Yang, Hongjuan Cui and Liang Yi

Br J Cancer 2017 116: 1572-1584; advance online publication, May 11, 2017; 10.1038/bjc.2017.126

Abstract | Full Text

BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses

E S Papadakis, T Reeves, N H Robson, T Maishman, G Packham and R I Cutress

Br J Cancer 2017 116: 1585-1594; advance online publication, May 16, 2017; 10.1038/bjc.2017.130

Abstract | Full Text

Clinical value of R-spondins in triple-negative and metaplastic breast cancers

F Coussy, F Lallemand, S Vacher, A Schnitzler, W Chemlali, M Caly, A Nicolas, S Richon, D Meseure, R El Botty, L De-Plater, L Fuhrmann, T Dubois, S Roman-Roman, V Dangles-Marie, E Marangoni and I Bièche

Br J Cancer 2017 116: 1595-1603; advance online publication, May 4, 2017; 10.1038/bjc.2017.131

Abstract | Full Text

Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer

Steffen Wagner, Claus Wittekindt, Shachi Jenny Sharma, Nora Wuerdemann, Theresa Jüttner, Miriam Reuschenbach, Elena-Sophie Prigge, Magnus von Knebel Doeberitz, Stefan Gattenlöhner, Ernst Burkhardt, Jörn Pons-Kühnemann and Jens Peter Klussmann

Br J Cancer 2017 116: 1604-1611; advance online publication, May 4, 2017; 10.1038/bjc.2017.132

Abstract | Full Text

The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance

Abdo Alnabulsi, Rebecca Swan, Beatriz Cash, Ayham Alnabulsi and Graeme I Murray

Br J Cancer 2017 116: 1612-1620; advance online publication, May 30, 2017; 10.1038/bjc.2017.135

Abstract | Full Text

Genetics & Genomics


Sequencing of DICER1 in sarcomas identifies biallelic somatic DICER1 mutations in an adult-onset embryonal rhabdomyosarcoma

Leanne de Kock, Barbara Rivera, Timothée Revil, Paul Thorner, Catherine Goudie, Dorothée Bouron-Dal Soglio, Catherine S Choong, John R Priest, Paul J van Diest, Jantima Tanboon, Anja Wagner, Jiannis Ragoussis, Peter FM Choong and William D Foulkes

Br J Cancer 2017 116: 1621-1626; advance online publication, May 18, 2017; 10.1038/bjc.2017.147

Abstract | Full Text



Pre-diagnosis diet and survival after a diagnosis of ovarian cancer

Mary C Playdon, Christina M Nagle, Torukiri I Ibiebele, Leah M Ferrucci, Melinda M Protani, Jonathan Carter, Simon E Hyde, Deborah Neesham, James L Nicklin, Susan T Mayne and Penelope M Webb for the Australian Ovarian Cancer Study Group

Br J Cancer 2017 116: 1627-1637; advance online publication, May 2, 2017; 10.1038/bjc.2017.120

Abstract | Full Text

The contribution of body mass index to appraisal delay in colorectal cancer diagnosis: a structural equation modelling study

Karen E Dyer, Levent Dumenci, Laura A Siminoff, Maria D Thomson and Jennifer Elston Lafata

Br J Cancer 2017 116: 1638-1642; advance online publication, May 2, 2017; 10.1038/bjc.2017.123

Abstract | Full Text

Herpes zoster risk after 21 specific cancers: population-based case–control study

Erik Hansson, Harriet J Forbes, Sinéad M Langan, Liam Smeeth and Krishnan Bhaskaran

Br J Cancer 2017 116: 1643-1651; advance online publication, May 2, 2017; 10.1038/bjc.2017.124

Abstract | Full Text

Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study

Ronan T Gray, Maurice B Loughrey, Peter Bankhead, Chris R Cardwell, Stephen McQuaid, Roisin F O'Neill, Kenneth Arthur, Victoria Bingham, Claire McGready, Anna T Gavin, Jacqueline A James, Peter W Hamilton, Manuel Salto-Tellez, Liam J Murray and Helen G Coleman

Br J Cancer 2017 116: 1652-1659; advance online publication, May 18, 2017; 10.1038/bjc.2017.139

Abstract | Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: